Egypt’s OTC drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Over-the-counter drugs are sold to the customer without a prescription from the doctor. They are typically used for minor health problems and are available at local pharmacies and shops. They are safe and effective when consumed according to the physician’s directions. OTC drugs can be readily available in pharmacies and online health websites worldwide. Over-the-counter drugs are generally taken off the shelf. OTC drugs also include dietary supplements which are intended to deliver desired nutrients to the body to increase the quantity of an individual’s diet.
In Egypt, although some form of subsidized healthcare to be introduced in the long run is expected, interest in OTCs is changing, with customers moving away from essential medicines like analgesics and into more evolved therapeutic categories like dermatological, digestives, and vitamins.
Market Drivers
Egypt’s OTC drug sector will continue to grow as rising health awareness and self-medication practices become more popular. Increasing awareness regarding health and willingness towards self-medication are key growth factors. Factors related to urbanization such as increasing pollution, and other lifestyle disorders and needs will also help drive the OTC sector in Egypt in the forecast period.
OTC medicines are especially helmed by low-income households and people without health insurance. With customers moving away from essential medicines like analgesics, into more evolved therapeutic categories like dermatological, digestives, and vitamins, interest in OTCs is changing. Due to this development, the OTC market will be well-placed to take advantage of Egypt’s growing middle class and increasingly affluent population over the medium to long term, despite the dominance of prescription medicines.
The OTC healthcare market, despite its relatively large size, suffers from an absence of advertising and consumer-orientated marketing.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Egypt’s Contraceptives market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Govt. of Egypt is committed to safeguarding the health of women and girls in the country and mitigating the rate of its population growth by expanding its contraceptive programs and improving the quality of services to attract new users while expanding contraceptive methods choice. Accordingly, the Strategic National Population Plan 2015-2030 in Egypt has called for accelerated efforts to reduce the TFR to 2.4 births per woman by the year 2030. Theoretically, such a fertility level can be achieved by increasing contraceptive prevalence from 58% in 2014 to 72%, thus increasing the demand for the market in the forecast period.
Social, cultural, and religious norms in Egypt have sometimes caused family planning to be stigmatized.
Market Drivers
With the rapid growth of the Egyptian population from 20.8 to 100 million inhabitants in the past 50 years, strenuous efforts have been made to promote maternal and child health through family planning programs that empower families to make informed decisions on the number of children and interval between children they want and to reduce unintended pregnancies. This will continue to boost the market for contraceptives in Egypt.
Rising rates of STDs have made people aware of contraceptives and the market is expected to sustain and grow through the forecast period.
Misconceptions about contraceptives still exist and this could factor in restraining the market growth in the country.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Egypt Telemedicine Market Report 2022 to 2030Insights10
The Egypt telemedicine market size is at around $170 Mn in 2022 and is projected to reach $717 Mn in 2030, exhibiting a CAGR of 19.7% during the forecast period. The driving factors for potential growth in the Egyptian market are the prevalence of chronic diseases, the increasing cost of healthcare, the 5G network, and so on. The telemedicine industry is segmented by component, modality, application, and delivery mode. It also shows competitive firms like Vezeeta, Clinido, Estshara, Schneider Electric, Siemens AG, and many more.
Report Overview
The China Telemedicine market size stood at around $ 19.5 million in 2019 and is projected to reach xx million by 2028, exhibiting a CAGR of xx% during the forecast period.
The penetration of Telemedicine in china was maintaining an increment of 6.6% over the years and with the Covid-19 outbreak the penetration show a gradual rise of 2% among the population of china which is expected to increase at a much higher rate in the following years. The market is primarily focused on the age group below 35 but they are working on compatibility and operability to cover middle aged and elderly age groups.
Market Drivers
The internet penetration and inclusion of 5G mobile technology contributed vastly for the development of telemedicine market in china. The uneven distribution and development of advanced healthcare infrastructure across the Chinese geography is one of the prime factors which caused the Chinese population of central and western region to shift to telemedicine. Massive Covid-19 infection and the lockdown has caused a large population to opt for telemedicine and is expected to register a CAGR of 23% by 2026. Also, the low physician to citizen ratio contributes to the greater adoption of telehealth in china.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Germany Physiotherapy Market Report 2022 to 2030Insights10
Germany's physiotherapy market analysis projects the growth of the physiotherapy market by $1.94 Bn in 2022 with a CAGR of 4.05% and is expected to reach $2.67 Bn in 2030. As physiotherapy concentrates more on rehabilitative and preventive treatments, the prevalence of cardiovascular and neurological disorders in geriatric populations are the main market drivers in the Germany physiotherapy market. The physiotherapy market is segmented by equipment, applications, and by end-users in Germany. Some leading companies in the physiotherapy market are BTL Industries, Performance Health, ITO Co. Ltd., and Enraf-Nonius B.V.
This report presents a strategic analysis of the Indian Dermatology
Therapeutics market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends
and insights, growth and demand drivers, challenges & future outlook,
etc. This is one of the most comprehensive reports about the Indian
Dermatology Therapeutics Market, offering unmatched value, accuracy
and expert insights.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The China Antiepileptic Drug market size stood at around USD XX billion in 2019 and is projected to reach USD 1.16 billion by 2028, exhibiting a CAGR of XX% during the forecast period.
The prevalence of epilepsy in China is 7%, and the prevalence of active epilepsy is 4.6%. In addition, there is a large gap in the treatment of epilepsy, which is about 63%. Based on this, it is estimated that the current epilepsy number of patients is more than 9 million, of which more than 6.4 million are patients with active epilepsy.
Market Drivers
Increasing incidence of neurological disorder and rising geriatric population are some factors driving the growth of Antiepileptic drugs market. Increasing advancement of drug modification and increasing number of available Antiepileptic drugs are some factors driving the growth of the market. Moreover, advancement in drugs provide small effects on liver metabolism that converts into a lower rate of side effects further contributing to the growth of Antiepileptic Drugs Market. Active government support and Investments are expediting the market growth. The R&D is now focused on the development of target specific drugs.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
This report presents a strategic analysis of the Canada Dermatology
Prescription market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends and
insights, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the Canada
Dermatology Prescription market, offering unmatched value, accuracy
and expert insights.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Egypt’s Contraceptives market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Govt. of Egypt is committed to safeguarding the health of women and girls in the country and mitigating the rate of its population growth by expanding its contraceptive programs and improving the quality of services to attract new users while expanding contraceptive methods choice. Accordingly, the Strategic National Population Plan 2015-2030 in Egypt has called for accelerated efforts to reduce the TFR to 2.4 births per woman by the year 2030. Theoretically, such a fertility level can be achieved by increasing contraceptive prevalence from 58% in 2014 to 72%, thus increasing the demand for the market in the forecast period.
Social, cultural, and religious norms in Egypt have sometimes caused family planning to be stigmatized.
Market Drivers
With the rapid growth of the Egyptian population from 20.8 to 100 million inhabitants in the past 50 years, strenuous efforts have been made to promote maternal and child health through family planning programs that empower families to make informed decisions on the number of children and interval between children they want and to reduce unintended pregnancies. This will continue to boost the market for contraceptives in Egypt.
Rising rates of STDs have made people aware of contraceptives and the market is expected to sustain and grow through the forecast period.
Misconceptions about contraceptives still exist and this could factor in restraining the market growth in the country.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Egypt Telemedicine Market Report 2022 to 2030Insights10
The Egypt telemedicine market size is at around $170 Mn in 2022 and is projected to reach $717 Mn in 2030, exhibiting a CAGR of 19.7% during the forecast period. The driving factors for potential growth in the Egyptian market are the prevalence of chronic diseases, the increasing cost of healthcare, the 5G network, and so on. The telemedicine industry is segmented by component, modality, application, and delivery mode. It also shows competitive firms like Vezeeta, Clinido, Estshara, Schneider Electric, Siemens AG, and many more.
Report Overview
The China Telemedicine market size stood at around $ 19.5 million in 2019 and is projected to reach xx million by 2028, exhibiting a CAGR of xx% during the forecast period.
The penetration of Telemedicine in china was maintaining an increment of 6.6% over the years and with the Covid-19 outbreak the penetration show a gradual rise of 2% among the population of china which is expected to increase at a much higher rate in the following years. The market is primarily focused on the age group below 35 but they are working on compatibility and operability to cover middle aged and elderly age groups.
Market Drivers
The internet penetration and inclusion of 5G mobile technology contributed vastly for the development of telemedicine market in china. The uneven distribution and development of advanced healthcare infrastructure across the Chinese geography is one of the prime factors which caused the Chinese population of central and western region to shift to telemedicine. Massive Covid-19 infection and the lockdown has caused a large population to opt for telemedicine and is expected to register a CAGR of 23% by 2026. Also, the low physician to citizen ratio contributes to the greater adoption of telehealth in china.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Germany Physiotherapy Market Report 2022 to 2030Insights10
Germany's physiotherapy market analysis projects the growth of the physiotherapy market by $1.94 Bn in 2022 with a CAGR of 4.05% and is expected to reach $2.67 Bn in 2030. As physiotherapy concentrates more on rehabilitative and preventive treatments, the prevalence of cardiovascular and neurological disorders in geriatric populations are the main market drivers in the Germany physiotherapy market. The physiotherapy market is segmented by equipment, applications, and by end-users in Germany. Some leading companies in the physiotherapy market are BTL Industries, Performance Health, ITO Co. Ltd., and Enraf-Nonius B.V.
This report presents a strategic analysis of the Indian Dermatology
Therapeutics market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends
and insights, growth and demand drivers, challenges & future outlook,
etc. This is one of the most comprehensive reports about the Indian
Dermatology Therapeutics Market, offering unmatched value, accuracy
and expert insights.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The China Antiepileptic Drug market size stood at around USD XX billion in 2019 and is projected to reach USD 1.16 billion by 2028, exhibiting a CAGR of XX% during the forecast period.
The prevalence of epilepsy in China is 7%, and the prevalence of active epilepsy is 4.6%. In addition, there is a large gap in the treatment of epilepsy, which is about 63%. Based on this, it is estimated that the current epilepsy number of patients is more than 9 million, of which more than 6.4 million are patients with active epilepsy.
Market Drivers
Increasing incidence of neurological disorder and rising geriatric population are some factors driving the growth of Antiepileptic drugs market. Increasing advancement of drug modification and increasing number of available Antiepileptic drugs are some factors driving the growth of the market. Moreover, advancement in drugs provide small effects on liver metabolism that converts into a lower rate of side effects further contributing to the growth of Antiepileptic Drugs Market. Active government support and Investments are expediting the market growth. The R&D is now focused on the development of target specific drugs.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
This report presents a strategic analysis of the Canada Dermatology
Prescription market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends and
insights, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the Canada
Dermatology Prescription market, offering unmatched value, accuracy
and expert insights.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Research Scope and Assumption
The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
Inflation has not been accounted for in order to estimate and forecast the market
Numbers may not add up due to rounding off
Reason to buy the report:
Facilitate decision-making based on strong current and forecast data for Poland Dental Care Market Analysis
Develop strategies based on the latest regulatory framework
Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Poland Dental Care Market Analysis
Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
To strategically profile key players and comprehensively analyze their market shares and core competencies
We have technically sound team which do a deep dive research and also provide strategy based consulting analysis
Poland Dental Care Market Analysis Executive Summary
The dental care market has undergone development for several decades. The NHS and private dentists work together to ensure that all residents can access essential care to maintain their oral health, while the wealthier population invests in privately paid complex treatments, including those of a cosmetic nature.
Market Size and Key Findings
The Poland Dental Care Market Analysis size stood at around USD xx% billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
India Physiotherapy Market Report 2022 to 2030Insights10
India's physiotherapy market size was valued at $0.96 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.85% from 2022 to 2030 and will reach $1.9 Bn in 2030. This market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The key players are BTL Industries. Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.
Egypt’s dental service market size was valued at USD xx billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of xx% from 2019 to 2028.
The dental service market caters to people’s oral hygiene and diseases needs. It consists of sales of dental services and related goods by entities (organizations, sole traders, and partnerships) that provide general dentistry, oral surgeries, and orthodontics and prosthodontic services. This industry comprises establishments of licensed health practitioners having a degree in D.M.D. – Doctor of Dental Medicine, D.D.S. – Doctor of Dental Surgery, or D.D.Sc. – Doctor of Dental Science.
Egypt has a fairly strong prevalence of dental issues. The country also increased the no. of dental colleges, leading to a rise in the no. of dental professionals in the country, although overall there still is a shortage of professionals relative to Egypt’s population size. In a study done in 2019 upon the children in the country, 74% of the total sample were found with dental caries.
Market Drivers
Oral hygiene awareness is one of the major contributors to market growth in the overall oral care/oral hygiene market through efforts made by dentists as well as key players in the market. These stakeholders conduct various seminars and programs to increase awareness of dental hygiene and demonstrate newly launched and technologically advanced products. This helps players to showcase their product portfolio, thereby raising the adoption of oral care products.
Rising demand for cosmetic dentistry has also set the market trajectory to rise in the forecast period. Further, the aging population, which has relatively higher dental care needs, is rapidly rising in Egypt and will boost the services market in the forecast period.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Canadian dermatological therapeutics market size stood at around USD 1.65 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Canadian skincare industry is growing tremendously at xx% from 2015-2019 and is forecasted to grow by xx% (2020-2028), as more Canadians are investing in their skincare and the market is driven by an aging population looking for solutions to maintaining healthy skin and younger. Technological advancements and the increasing prevalence of skincare are anticipated to fuel the growth.
Market Drivers
Canada’s market is majorly driven by the rising burden of dermatology diseases. The skincare market is driven by the consumer attitude that is, to improve their quality of life in terms of looks and this attitude is visible across all the age groups. The Growing demand for anti-aging products and innovative and eco-friendly packaging designs are attributing to the market growth in the country. Canada’s skin allergy market is forecasted to grow by 3.9% over the 2020-2027 period. The extensive presence of online retail channels is also influencing sales of cosmetics in the country. The collective incidence of dermatological diseases and increasing levels of awareness-related disease progression, Etiology, and available therapies are leading to the high growth of dermatological therapeutics.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Japan telemedicine market size stood at around USD 220 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Modern ICTs are revolutionizing how individuals communicate with each other, seek and exchange information, and enriching their lives. These technologies have great potential to help address modern health issues. These recent advancements in, and increasing availability and utilization of, ICTs have been creating new possibilities for health care service and delivery. The replacement of analogue forms of communication with digital methods, combined with a rapid drop in the cost, have sparked wide interest in the application of telemedicine, and have enabled health care organizations to envision and implement new and more efficient ways of providing care. The introduction and popularization of the Internet have further accelerated the pace of ICT advancements, thereby expanding the scope of telemedicine to encompass Web-based applications (e.g. e-mail, teleconsultations and conferences via the Internet etc.) and multimedia approaches (e.g. digital imagery and video etc.)
Market Drivers
Several factors are contributing to the rapid rise of telehealth companies as the sector looks beyond tele stroke, remote patient monitoring, and other routine services. Specialized fields are starting to invest in telemedicine apps and software programs. New features like Artificial Intelligence, predictive analytics, and automated data collection are being used to lower the cost of care, improve patient engagement and accessibility. Regulatory agencies are also adopting the idea of digital healthcare, opening the door for new companies to capitalize on this trend.
Type of Services
Telemedicine services are further sub-classified into telemonitoring, tele-consulting, and tele-education. The telemonitoring segment is expected to grow over the forecast period owing to the increasing base of geriatric population requiring home assistance for care delivery. The Tele-consulting segment is anticipated to be the lucrative segment over the forecast period owing to the rising initiatives by the government for telehealth implementation projects and high demand for video conferencing solutions.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Indian Home Healthcare market size was valued at USD 5.2 Billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 19.2% from 2019 to 2028.
The increasing incidence of chronic diseases and the need for better primary and postoperative care has enhanced market growth Homecare in India. According to the World Health Organization (WHO), chronic and lifestyle diseases are expected to increase by XX% in India. Due to COVID-19 Pandemic, home healthcare services are considered to be safer and cost-effective alternative to hospital services for non-emergent cases. Home Healthcare in India is growing by 15-19% a year to touch $11-13 billion by 2025 from $5.4 billion.
Market Drivers
To avoid risk of getting infected, lack of personal care, to reduce the unnecessary hospital visits and high hospitalization costs are the major drivers that consumers are looking at home healthcare as the emerging solution. As the prevalence of lifestyle diseases, rising demand for quality and affordable care the need of Home Healthcare has increased. Home Healthcare Provides ICU services at 50% cheaper rate than the hospitals. ICU facility at Home with equipment and medical expertise ranges between Rs 7,500 to Rs 10,000 a day.
Type of Home Healthcare Services
The Home Healthcare market is further segmented by type of service into Physician/Primary Care, Nursing Care, Physical Occupational and Speech Therapy, Nutritional Support, Hospice & Palliative, Other Skilled Homecare Services. Primary care and Nursing care is dominating homecare services covering around XX% of Homecare Market in India.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
INDIA MEDICAL DEVICE REGULATORY LANDSCAPEInsights10
The Indian medical device regulatory landscape is constantly evolving. In recent years, the government has implemented several new regulations to improve the safety and quality of medical devices. This has created new challenges and opportunities for medical device manufacturers and importers. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3T4fMvE
Promising New Cancer Drugs Jan 2024 by Insights10Insights10
Medtech Monday: Bullish Bets on Breakthroughs - Examining Cutting-Edge Trials and Investment Opportunities Attention all healthcare and biotech investors! Buckle up for a deep dive into the hottest clinical trials poised to shape the future of medicine in 2024 and beyond. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3uGcvZW
Patient - First Health With Generative AIInsights10
Patient-First Health With Generative AI Learn about the groundbreaking potential of #GenerativeAI in patient engagement, including its three broad categories of use cases. Understand why this innovation is poised to revolutionize patient interaction with their health and the crucial steps stakeholders must take to bring it to fruition. Don't miss this essential read by Insights10 for anyone passionate about the intersection of AI and healthcare! To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/42OOgWa
Vietnam In-Vitro Fertilization (IVF) Service Market AnalysisInsights10
This report presents a strategic analysis of Vietnam In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Turkey nutrition and supplements market will reach a value of $6.08 Mn from $3.05 Mn in 2022, growing at a CAGR of 9% during 2022-2030. The nutritional supplements market in Turkey is primarily dominated by local players such as Form Labs, Hülya Şahin, and Solgar. To get a detailed report, contact us at - info@insights10.com
Spain Artificial Intelligence (AI) in Healthcare Market AnalysisInsights10
Spain's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.13 Bn in 2022 to $2.49 Bn by 2030, registering a CAGR of 44.22% during the forecast period of 2022-2030. The market will be driven by the government's support and increasing industry collaborations. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Methinks & IOMED. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Global Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. To get a detailed report, contact us at - info@insights10.com
The Kenya home healthcare market was valued at $XX Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the aging population. The market is segmented by indication and product. To get a detailed report, contact us at - info@insights10.com
Japan Nutritional Supplements Market Analysis.pdfInsights10
By 2030, it is anticipated that the Japan Nutrition and Supplements market will reach a value of $47.25 Bn from $23.71 Bn in 2022, growing at a CAGR of 9% during 2022-30. The market is primarily dominated by local players such as Otsuka Pharmaceutical, Taisho Pharmaceutical, Kikkoman Corporation, and Ajinomoto.To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Australian dermatology drugs market will reach a value of $516 Mn from $204 Mn in 2022, growing at a CAGR of 12.3% during 2022-2030. The market is primarily dominated by local players such as Faulding, Bioscience International, Aspen Pharmacare, and Alpha Pharm. The market is driven by an aging population, disparities in universal health coverage, and the launch of new and innovative drugs. To get a detailed report, contact us at - info@insights10.com
India 3D Printing Medical Devices Market AnalysisInsights10
India's 3D printing medical devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030. The market is segmented by component, application, technology, and end user. To get a detailed report, contact us at - info@insights10.com
Australia Nutritional Supplements Market AnalysisInsights10
By 2030, it is anticipated that the Australian nutrition and supplements market will reach a value of $9.81 Bn from $4.58 Bn in 2022, growing at a CAGR of 10% during 2022-30. The market is primarily dominated by local players such as Blackmores, BioMedicals, Nutralife, and Life-Space. To get a detailed report, contact us at - info@insights10.com
Hong Kong Pharmaceutical Market AnalysisInsights10
This report presents a strategic analysis of the Hong Kong Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth.To get a detailed report, contact us at - info@insights10.com
Australia's healthcare diagnostic market is valued at $xx Bn in 2022 and would likely grow at a CAGR of 1.5% during 2022-2030. The Australia healthcare diagnostic market is segmented by product, end-user, and test type. The factors affecting its growth are prevalent chronic diseases, the rising geriatric population, insurance and reimbursement, and regulating bodies. To get a detailed report, contact us at - info@insights10.com
Mexico's connected healthcare market is projected to grow from $995.4 Mn in 2022 to $7469.23 Mn by 2030, registering a CAGR of 28.65% during the forecast period of 2022-30. The main factors driving the growth would be increasing technological adoption, the aging population, the rising prevalence of chronic diseases, and government support. To get a detailed report, contact us at - info@insights10.com
Research Scope and Assumption
The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
Inflation has not been accounted for in order to estimate and forecast the market
Numbers may not add up due to rounding off
Reason to buy the report:
Facilitate decision-making based on strong current and forecast data for Poland Dental Care Market Analysis
Develop strategies based on the latest regulatory framework
Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Poland Dental Care Market Analysis
Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
To strategically profile key players and comprehensively analyze their market shares and core competencies
We have technically sound team which do a deep dive research and also provide strategy based consulting analysis
Poland Dental Care Market Analysis Executive Summary
The dental care market has undergone development for several decades. The NHS and private dentists work together to ensure that all residents can access essential care to maintain their oral health, while the wealthier population invests in privately paid complex treatments, including those of a cosmetic nature.
Market Size and Key Findings
The Poland Dental Care Market Analysis size stood at around USD xx% billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
India Physiotherapy Market Report 2022 to 2030Insights10
India's physiotherapy market size was valued at $0.96 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.85% from 2022 to 2030 and will reach $1.9 Bn in 2030. This market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The key players are BTL Industries. Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.
Egypt’s dental service market size was valued at USD xx billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of xx% from 2019 to 2028.
The dental service market caters to people’s oral hygiene and diseases needs. It consists of sales of dental services and related goods by entities (organizations, sole traders, and partnerships) that provide general dentistry, oral surgeries, and orthodontics and prosthodontic services. This industry comprises establishments of licensed health practitioners having a degree in D.M.D. – Doctor of Dental Medicine, D.D.S. – Doctor of Dental Surgery, or D.D.Sc. – Doctor of Dental Science.
Egypt has a fairly strong prevalence of dental issues. The country also increased the no. of dental colleges, leading to a rise in the no. of dental professionals in the country, although overall there still is a shortage of professionals relative to Egypt’s population size. In a study done in 2019 upon the children in the country, 74% of the total sample were found with dental caries.
Market Drivers
Oral hygiene awareness is one of the major contributors to market growth in the overall oral care/oral hygiene market through efforts made by dentists as well as key players in the market. These stakeholders conduct various seminars and programs to increase awareness of dental hygiene and demonstrate newly launched and technologically advanced products. This helps players to showcase their product portfolio, thereby raising the adoption of oral care products.
Rising demand for cosmetic dentistry has also set the market trajectory to rise in the forecast period. Further, the aging population, which has relatively higher dental care needs, is rapidly rising in Egypt and will boost the services market in the forecast period.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Canadian dermatological therapeutics market size stood at around USD 1.65 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Canadian skincare industry is growing tremendously at xx% from 2015-2019 and is forecasted to grow by xx% (2020-2028), as more Canadians are investing in their skincare and the market is driven by an aging population looking for solutions to maintaining healthy skin and younger. Technological advancements and the increasing prevalence of skincare are anticipated to fuel the growth.
Market Drivers
Canada’s market is majorly driven by the rising burden of dermatology diseases. The skincare market is driven by the consumer attitude that is, to improve their quality of life in terms of looks and this attitude is visible across all the age groups. The Growing demand for anti-aging products and innovative and eco-friendly packaging designs are attributing to the market growth in the country. Canada’s skin allergy market is forecasted to grow by 3.9% over the 2020-2027 period. The extensive presence of online retail channels is also influencing sales of cosmetics in the country. The collective incidence of dermatological diseases and increasing levels of awareness-related disease progression, Etiology, and available therapies are leading to the high growth of dermatological therapeutics.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Japan telemedicine market size stood at around USD 220 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Modern ICTs are revolutionizing how individuals communicate with each other, seek and exchange information, and enriching their lives. These technologies have great potential to help address modern health issues. These recent advancements in, and increasing availability and utilization of, ICTs have been creating new possibilities for health care service and delivery. The replacement of analogue forms of communication with digital methods, combined with a rapid drop in the cost, have sparked wide interest in the application of telemedicine, and have enabled health care organizations to envision and implement new and more efficient ways of providing care. The introduction and popularization of the Internet have further accelerated the pace of ICT advancements, thereby expanding the scope of telemedicine to encompass Web-based applications (e.g. e-mail, teleconsultations and conferences via the Internet etc.) and multimedia approaches (e.g. digital imagery and video etc.)
Market Drivers
Several factors are contributing to the rapid rise of telehealth companies as the sector looks beyond tele stroke, remote patient monitoring, and other routine services. Specialized fields are starting to invest in telemedicine apps and software programs. New features like Artificial Intelligence, predictive analytics, and automated data collection are being used to lower the cost of care, improve patient engagement and accessibility. Regulatory agencies are also adopting the idea of digital healthcare, opening the door for new companies to capitalize on this trend.
Type of Services
Telemedicine services are further sub-classified into telemonitoring, tele-consulting, and tele-education. The telemonitoring segment is expected to grow over the forecast period owing to the increasing base of geriatric population requiring home assistance for care delivery. The Tele-consulting segment is anticipated to be the lucrative segment over the forecast period owing to the rising initiatives by the government for telehealth implementation projects and high demand for video conferencing solutions.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Indian Home Healthcare market size was valued at USD 5.2 Billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 19.2% from 2019 to 2028.
The increasing incidence of chronic diseases and the need for better primary and postoperative care has enhanced market growth Homecare in India. According to the World Health Organization (WHO), chronic and lifestyle diseases are expected to increase by XX% in India. Due to COVID-19 Pandemic, home healthcare services are considered to be safer and cost-effective alternative to hospital services for non-emergent cases. Home Healthcare in India is growing by 15-19% a year to touch $11-13 billion by 2025 from $5.4 billion.
Market Drivers
To avoid risk of getting infected, lack of personal care, to reduce the unnecessary hospital visits and high hospitalization costs are the major drivers that consumers are looking at home healthcare as the emerging solution. As the prevalence of lifestyle diseases, rising demand for quality and affordable care the need of Home Healthcare has increased. Home Healthcare Provides ICU services at 50% cheaper rate than the hospitals. ICU facility at Home with equipment and medical expertise ranges between Rs 7,500 to Rs 10,000 a day.
Type of Home Healthcare Services
The Home Healthcare market is further segmented by type of service into Physician/Primary Care, Nursing Care, Physical Occupational and Speech Therapy, Nutritional Support, Hospice & Palliative, Other Skilled Homecare Services. Primary care and Nursing care is dominating homecare services covering around XX% of Homecare Market in India.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
INDIA MEDICAL DEVICE REGULATORY LANDSCAPEInsights10
The Indian medical device regulatory landscape is constantly evolving. In recent years, the government has implemented several new regulations to improve the safety and quality of medical devices. This has created new challenges and opportunities for medical device manufacturers and importers. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3T4fMvE
Promising New Cancer Drugs Jan 2024 by Insights10Insights10
Medtech Monday: Bullish Bets on Breakthroughs - Examining Cutting-Edge Trials and Investment Opportunities Attention all healthcare and biotech investors! Buckle up for a deep dive into the hottest clinical trials poised to shape the future of medicine in 2024 and beyond. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3uGcvZW
Patient - First Health With Generative AIInsights10
Patient-First Health With Generative AI Learn about the groundbreaking potential of #GenerativeAI in patient engagement, including its three broad categories of use cases. Understand why this innovation is poised to revolutionize patient interaction with their health and the crucial steps stakeholders must take to bring it to fruition. Don't miss this essential read by Insights10 for anyone passionate about the intersection of AI and healthcare! To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/42OOgWa
Vietnam In-Vitro Fertilization (IVF) Service Market AnalysisInsights10
This report presents a strategic analysis of Vietnam In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Turkey nutrition and supplements market will reach a value of $6.08 Mn from $3.05 Mn in 2022, growing at a CAGR of 9% during 2022-2030. The nutritional supplements market in Turkey is primarily dominated by local players such as Form Labs, Hülya Şahin, and Solgar. To get a detailed report, contact us at - info@insights10.com
Spain Artificial Intelligence (AI) in Healthcare Market AnalysisInsights10
Spain's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.13 Bn in 2022 to $2.49 Bn by 2030, registering a CAGR of 44.22% during the forecast period of 2022-2030. The market will be driven by the government's support and increasing industry collaborations. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Methinks & IOMED. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Global Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. To get a detailed report, contact us at - info@insights10.com
The Kenya home healthcare market was valued at $XX Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the aging population. The market is segmented by indication and product. To get a detailed report, contact us at - info@insights10.com
Japan Nutritional Supplements Market Analysis.pdfInsights10
By 2030, it is anticipated that the Japan Nutrition and Supplements market will reach a value of $47.25 Bn from $23.71 Bn in 2022, growing at a CAGR of 9% during 2022-30. The market is primarily dominated by local players such as Otsuka Pharmaceutical, Taisho Pharmaceutical, Kikkoman Corporation, and Ajinomoto.To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Australian dermatology drugs market will reach a value of $516 Mn from $204 Mn in 2022, growing at a CAGR of 12.3% during 2022-2030. The market is primarily dominated by local players such as Faulding, Bioscience International, Aspen Pharmacare, and Alpha Pharm. The market is driven by an aging population, disparities in universal health coverage, and the launch of new and innovative drugs. To get a detailed report, contact us at - info@insights10.com
India 3D Printing Medical Devices Market AnalysisInsights10
India's 3D printing medical devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030. The market is segmented by component, application, technology, and end user. To get a detailed report, contact us at - info@insights10.com
Australia Nutritional Supplements Market AnalysisInsights10
By 2030, it is anticipated that the Australian nutrition and supplements market will reach a value of $9.81 Bn from $4.58 Bn in 2022, growing at a CAGR of 10% during 2022-30. The market is primarily dominated by local players such as Blackmores, BioMedicals, Nutralife, and Life-Space. To get a detailed report, contact us at - info@insights10.com
Hong Kong Pharmaceutical Market AnalysisInsights10
This report presents a strategic analysis of the Hong Kong Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth.To get a detailed report, contact us at - info@insights10.com
Australia's healthcare diagnostic market is valued at $xx Bn in 2022 and would likely grow at a CAGR of 1.5% during 2022-2030. The Australia healthcare diagnostic market is segmented by product, end-user, and test type. The factors affecting its growth are prevalent chronic diseases, the rising geriatric population, insurance and reimbursement, and regulating bodies. To get a detailed report, contact us at - info@insights10.com
Mexico's connected healthcare market is projected to grow from $995.4 Mn in 2022 to $7469.23 Mn by 2030, registering a CAGR of 28.65% during the forecast period of 2022-30. The main factors driving the growth would be increasing technological adoption, the aging population, the rising prevalence of chronic diseases, and government support. To get a detailed report, contact us at - info@insights10.com
Global Clinical Trial Support Services Market AnalysisInsights10
This report presents a strategic analysis of the Global Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
South Africa Nutritional Supplements Market AnalysisInsights10
By 2030, it is anticipated that the South Africa Nutrition and Supplements market will reach a value of $xx Bn from $2.48 Bn Mn in 2022, growing at a CAGR of xx% during 2022-2030. The nutritional supplements market in South Africa is primarily dominated by local players such as Solal Technologies Aspen Pharmacare and Adcock Ingram. To get a detailed report, contact us at - info@insights10.com
Bulgaria Over The Counter (OTC) Pharmaceuticals Market AnalysisInsights10
Bulgaria's over-the-counter (OTC) pharmaceuticals market size was valued at $137.5 Mn in 2022 and is estimated to expand at a CAGR of 6.52% from 2022 to 2030 and will reach $227.9 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Japan Radiotherapy Market will reach a value of $711 Mn from $430 Mn in 2022, growing at a CAGR of 6.5% during 2022-30. The Radiotherapy Therapeutics Market in Japan is dominated by a few domestic players such as Hitachi, Mitsubishi Electric Corporation, and IHI Corporation. The radiotherapy market in Japan is segmented into different types, technologies, procedures, applications, and end-users.
To get a detailed report, contact us at - info@insights10.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
NVBDCP.pptx Nation vector borne disease control program
Egypt OTC Drug Market
1.
2. Egypt OTC
Market Analysis
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2021 – 2030)
www.insights10.com
3. This report presents a strategic analysis of the Egyptian OTC
medicines market and a forecast for its development in the medium and
long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, characteristics, main players, trends and
insights, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the Egyptian OTC
medicines market, offering unmatched value, accuracy and expert
insights.
4. The report is prepared
using a proven
methodology and
insightful research.
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make smarter
business and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more.
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works.
Easy to read
What kind of data is presented
in this Report?
This report presents data, which is:
5. 5 A Sample Report on Egypt OTC Market I Confidential
Table of Contents
1. Methodology and Scope…………………………………………………………………….…………………………………………………..….08
1.1 Research Methodology
1.2 Analysis Methodology
1.3 Research Approach
1.4 Key benefits for stakeholders
2. Egypt OTC Market Overview…………………………………………………………………………………………………………………..…...14
2.1 Introduction
2.2 Market size and forecast
3. Market Growth Drivers and Restraints …………………………………………………………………….…………………………………….17
3.1 Market Growth Drivers
3.1.1 Rising Awareness
3.1.2 Increasing Population due to Urbanization
3.1.3 Change in Preferences from Prescription to OTC
3.1.4 Rise in Income of the Population
3.2 Market Restraints
3.2.1 Side Effects of few over the counter pills
3.2.2 Lack of advertising and reaching out to customers
3.2.3 Lack of Awareness & Government Control
6. 6 A Sample Report on Egypt OTC Market I Confidential
Table of Contents (continued)
4. Major Types of OTC Drugs…..……………………………………………………………………………………..…………………….…..…..24
4.1 Analgesics
4.2 Cough, Cold and Flu Products
4.3 Vitamins and Minerals
4.4 Skincare Products
4.5 Anti Allergic Drugs (Antihistamines)
4.5 Gastrointestinal Products
4.6 Opthalmic Products
4.7 Sleep Aid Products
5. Drugs Market Segmentation………………………………………………………………………………………………………..…………….27
5.1 By Product Type
5.2 By Formulation
5.3 By Distribution Channel
7. 7 A Sample Report on Egypt OTC Market I Confidential
Table of Contents (continued)
6. OTC Major Drug Market Share……………………………………………………………………………...…………..….......………………..….32
6.1 Market Analysis, Insights and Forecast - By Revenue
7. Competitive Landscape……………………………………………………………………………………………………….…………………...….34
7.1 Major Player
7.2 Products in Pipeline
8. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….…………………………………………......37
8.1 GlaxoSmithKline
8.2 Johnson and Johnson
8.3 Novartis
8.4 Bayer
8.5 Pfizer
9. Healthcare Policies and Regulatory Landscape………………………………….………………………………………………………………48
9.1 Regulatory Framework of Egyptian Drug Market
10. Factors Driving Future Growth……………………………………………………………………………………………………………….…….51
9. 9 A Sample Report on Egypt OTC Market I Confidential
Research Methodology
Insights 10’s research methodology delves deep into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conducted extensive data mining, referring to verified data sources such as independent studies,
government and regulatory published material, technical journals, trade magazines, and paid data sources
For forecasting, the following parameters were considered:
Market drivers and restraints along with their current and expected impacts
Technological scenario and expected developments
End use industry trends and dynamics
Trends in the consumer behavior
Regulatory scenario and expected developments
Current capacity and expected capacity additions up to 2030
We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the
expected market growth rate
We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
All our estimates and forecasts were verified through exhaustive primary research with the Key Industry Participants (KIPs)
10. 10 A Sample Report on Egypt OTC Market I Confidential
Analysis Methodology
• Final Market Size Break-up to Rest of
Segmentation i.e., Product and Services,
Type, Specialty, Delivery Mode and
Geography, etc
• Arriving at the Market Size of each Segment
• Data Validation with Primary Interviews
• Final Market Size
• Validation from Primary Interview
• Summation of Revenue Generated from
Companies to Arrive at Total Market Size
• Revenue Generated by Products and
Services offered by Companies
Top Down Analysis
Bottom-up Analysis
11. 11 A Sample Report on Egypt OTC Market I Confidential
Research Approach
The data presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Data Collection
• Primary Interviews (Industry Participants,
Outside experts)
• Secondary Data
Company Reports and Publications,
Government Data, Financial Reports of Key
Industry Players, Press Releases, Scientific
and Industry Publications and Whitepapers
Market Data Analysis &
Statistical Model
• Market Trends
• Market Sizing and Analysis
• Data Triangulation & Validation
Market Trends such as Drivers, Restraints,
Opportunities, Challenges. An intensive
cross-verification and validation process
Interpretation and
Presentation
• Analysis & Interpretation
• Insights
• Presentation & Reporting
The information gathered is then analyzed
and synthesized. The market research
report is presented in different forms such
as charts by using a scientific approach for
easy understanding
12. 12 A Sample Report on Egypt OTC Market I Confidential
Key Benefit for Stakeholders from this report
The study provides an in-depth analysis of the Egypt OTC Drug Market with current trends and future estimations to elucidate
the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030 is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
13. “Egypt is not just a sun-soaked
paradise defined by pyramids and
tombs, or a hotbed for political
turmoil and revolution. It’s also a
vibrant and growing market for
pharmaceuticals & OTC Products.”
14. A Sample Report on Egypt OTC Market
Egypt OTC Market Analysis :
Market Overview
15. 15 A Sample Report on Egypt OTC Market I Confidential
Introduction
The Egypt OTC Drugs Market is likely to record a considerable growth rate in the
coming years
The key growth factors include growth of middle class, increasing disposable income,
rapid population growth , greater health awareness and willingness to self-medicate.
Increasing urbanization will also help drive the OTC sector in Egypt, as more of the
population is affected by issues such as pollution
Accessibility of super markets and emerging retail channels are also contributing to the
growth of the OTC Drug market in Egypt
16. 16 A Sample Report on Egypt OTC Market I Confidential
Egypt OTC Market Size $Mn) 2022-2030F
Egypt OTC Market Analysis (Current and Forecast)
Egypt OTC market size stood at around USD XX million in
2022 and is projected to reach USD XX million by 2030,
exhibiting a CAGR of around XX.X% during the forecast
period
Egypt's OTC drug sector will continue to grow as rising
health awareness and self-medication practices become
more popular
In Egypt, some form of subsidized healthcare to be
introduced in the long run is expected, interest in OTCs is
changing, with customers moving away from essential
medicines like analgesics and into more evolved therapeutic
categories like dermatological, digestives, and vitamins
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Key Analysis
$XX Mn
$XX Mn
17. A Sample Report on Egypt OTC Market
Egypt OTC Market Analysis :
Growth Drivers and Growth Restraints
18. 18 A Sample Report on Egypt OTC Market I Confidential
Market Growth Drivers
Market
Drivers
Market
Restraints
Market
Drivers
Rising health awareness and self-
medication practices
Factors related to urbanization are
highly responsible for the OTC market
growth
Technological Advancements, Product
Innovation are factors for emerging OTC
Market in Egypt
Strong growth is anticipated as per
increased government investments
in healthcare
19. 19 A Sample Report on Egypt OTC Market I Confidential
Market Growth Drivers
1. Rising health awareness and self-medication practices
Egypt’s OTC drug sector will continue to grow as rising health awareness and self-medication practices
become more popular
Increasing awareness regarding health and willingness towards self-medication are key growth factors.
Self-Medication for mild health problems, the convenience of direct purchase
Sample
20. 20 A Sample Report on Egypt OTC Market I Confidential
Market Growth Drivers (continued)
Factors related to urbanization such as increasing pollution, and other lifestyle disorders and needs will
also help drive the OTC sector in Egypt in the forecast period
OTC medicines are especially helmed by low-income households and people without health insurance.
With customers moving away from essential medicines like analgesics, into more evolved therapeutic
categories like dermatological, digestives, and vitamins, interest in OTCs is changing
2. Factors related to urbanization are highly responsible for the OTC market growth
Sample
21. 21 A Sample Report on Egypt OTC Market I Confidential
Market Growth Drivers (continued)
3. Technological Advancements, Product Innovation are factors for emerging OTC
Market in Egypt
Product innovation, high penetration in emerging markets, a favorable regulatory framework,
and the trend for pharmaceutical companies to shift from prescription to OTC are the growth
drivers of the OTC Market Egypt
With technological advancements and product innovation, SMEs are expanding their market
presence by introducing new products at lower prices.
Sample
22. 22 A Sample Report on Egypt OTC Market I Confidential
Market Growth Drivers (continued)
4. Strong growth is anticipated as per increased government investments in
healthcare
Sample
Due to this development, the OTC market will be well-placed to take advantage of Egypt’s growing middle
class and increasingly affluent population over the medium to long term, despite the dominance of prescription
medicine
Government investments are increasing with the growth of healthcare industry which is helpful in development
of Over the counters drug market in Egypt
23. 23 A Sample Report on Egypt OTC Market I Confidential
Side Effects of few over the counter pills
Lack of advertising and reaching out to
customers
Market Restraints
Despite its size, the OTC healthcare market
suffers from a lack of advertising and
consumer-oriented marketing.
The market for OTC drugs is highly competitive,
with several key players. The intense market
competition, combined with the side effects
associated with a few pills, may stymie the
market's rapid expansion.
Lack Of Awareness & Govt Control
The OTC market development has been
hampered by factors such as the lack of
healthcare awareness among patients and the
low prices of OTC medicines, which are rigidly
controlled by the Ministry of Health
24. A Sample Report on Egypt OTC Market
Egypt OTC Market Analysis:
Major OTC Drugs
25. 25 A Sample Report on Egypt OTC Market I Confidential
Major OTC Drugs
Analgesics Cough, Cold and
Flu Products
There are lots of different
cold and cough
medicines, and they do
different things: Nasal
decongestants - unclog a
stuffy nose.
Cough suppressants -
quiet a cough.
Expectorants - loosen
mucus in your lungs so
you can cough it up.
Antihistamines - stop
runny noses and
sneezing.
Skincare Products
OTC dermatology drugs are
an accepted treatment for
many common medical
problems, including
musculoskeletal pain,
headaches, cold symptoms,
allergies, heartburn, and
dermatitis.
I Analgesics are
medications that relieve
pain.
Unlike medications used
for anesthesia during
surgery, analgesics don't
turn off nerves, change
the ability to sense your
surroundings or alter
consciousness.
Vitamin and mineral rich
supplements have
medicinal properties which
offer healing benefits
apart from fulfilling daily
required nutrients. It helps
in building a strong
immune system against
common diseases. .
Vitamins and Minerals
26. 26 A Sample Report on Egypt OTC Market I Confidential
Major OTC Drugs
Sample
Anti Allergic Drugs Gastrointestinal Products Ophthalmic Products
Most over-the-counter (OTC)
ophthalmic drugs contain
humectants (substances that
help retain moisture),
lubricants, and electrolytes,
such as potassium which
help in providing extra
moisture to the eyes and can
be used as per the directions
given
Sleep Aid Products
Sample
Sample
27. A Sample Report on Egypt OTC Market
Egypt OTC Market Analysis :
Market Segmentation
28. 28 A Sample Report on Egypt OTC Market I Confidential
Egypt OTC Market Segmentation
By Product Type
Egypt OTC Market Segmentation
By Formulation By Distribution Channel
Vitamins and Minerals
Dermatological Products
Analgesics Cough, Cold and
Flu , Anti AllergicProducts
Gastrointestinal Products
Ophthalmic Products
Sleep Aid Products
Weight Loss/Diet Products
Tablets (Oral)
Liquids (Oral)
Ointments (Topical)
Sprays (Topical)
Convenience Stores
Pharmacies
Supermarkets
Online Stores
29. 29 A Sample Report on Egypt OTC Market I Confidential
By Product Type Egypt OTC drugs segments the market
into Analgesics Cough, Cold and Flu Products, Vitamins
and Minerals, Dermatological Products, Gastrointestinal
Products, Ophthalmic Products, Sleep Aid Products,
Weight Loss/Diet Products, Others
Market Segmentation: By Product Type
Egypt OTC Market Share by Product Type 2022
Key Insights
Analgesics,Cough & Cold, Anti Allergic Vitamins and Minerals
Dermatological Products Gastrointestinal Products
Ophthalmic Products Sleep Aid Products
Weight Loss/Diet Products
30. 30 A Sample Report on Egypt OTC Market I Confidential
Market Segmentation: By Formulation
Egypt OTC Market Share By Formulation 2022
Egypt OTC Market is segmented into Tablets, Liquids,
Ointments, and Sprays by formulation
Key Insights
Tablets Liquids Ointments Corticosteroids
31. 31 A Sample Report on Egypt OTC Market I Confidential
Market Segmentation: By Distribution Channels
Egypt OTC Market Share by Distribution Channel 2022
The Egypt OTC Market is segmented into Online
Pharmacies, Supermarkets, Convenience Stores, and
Online Stores by the Distribution Channels
Hospitals remain the primary point of access for
healthcare services, and the distribution of consumer
health products is only permitted through pharmacies
Key Insights
Pharmacies Supermarkets Convenience Stores Online Stores
32. A Sample Report on Egypt OTC Market
Egypt OTC Market Analysis :
OTC Major Products Market Share
33. 33 A Sample Report on Egypt OTC Market I Confidential
TOP BRANDS IN EGYPT OTC MARKET
Major OTC Products Market Share
Key Insights
Egypt OTC Major Products Market Share
Brand 1 Brand 2 Brand3 Brand 4
34. A Sample Report on Egypt OTC Market
Egypt OTC Market Analysis :
Competitive Landscape
35. 35 A Sample Report on Egypt OTC Market I Confidential
Key Players
36. 36 A Sample Report on Egypt OTC Market I Confidential
Key Players Revenue (Current and Forecast)
2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
GlaxoSmithKline XX - - - - - - - -
Johnson and
Johnson
XX - - - - - - - -
Novartis XX - - - - - - - -
Bayer XX - - - - - - - -
Pfizer XX - - - - - - - -
Major Market Revenue of Egypt OTC ($Bn)
37. 37 A Sample Report on Egypt OTC Market I Confidential
Key Players by Revenue Growth and Market Share
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
Johnson & Johnson
Novartis
Bayer
Pfizer
Glaxosmith
Key Players Egypt OTC ($Bn)
Revenue Market Share Growth
39. 39 A Sample Report on Egypt OTC Market I Confidential
Glaxo SmithKline
Company Profile
Company Name: Glaxo SmithKline
Year of Establishment: 2000
Headquarter: London, UK
Revenue: $42.11 Bn
Website: https://www.gsk.com/en-gb/home/
Sample
40. 40 A Sample Report on Egypt OTC Market I Confidential
Glaxo SmithKline (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030
XX
XX
Sample
1 2 3 4
41. 41 A Sample Report on Egypt OTC Market I Confidential
Sample
Company Name: Johnson and Johnson
Year of Establishment: 1886
Headquarter: New Jersey, United States
Revenue: $93.77 Bn
Website: https://www.jnj.com/
Company Profile
Johnson and Johnson
42. 42 A Sample Report on Egypt OTC Market I Confidential
Johnson and Johnson (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030)
XX
XX
Sample
1 2 3 4
43. 43 A Sample Report on Egypt OTC Market I Confidential
Sample
Company Name: Novartis
Year of Establishment: 1885
Headquarter: Basel, Switzerland
Revenue: $49.89 Bn
Website: https://www.Novartis.com
Company Profile
Novartis
44. 44 A Sample Report on Egypt OTC Market I Confidential
Novartis (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030
XX
XX
Sample
1 2 3 4
45. 45 A Sample Report on Egypt OTC Market I Confidential
Sample
Company Name: Bayer
Year of Establishment: 1863
Headquarter: Leverkusen, Germany
Revenue: $46.50 Bn
Website: https://www.bayer.com
Company Profile
Bayer
46. 46 A Sample Report on Egypt OTC Market I Confidential
Bayer (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030
XX
XX
Sample
1 2 3 4
47. 47 A Sample Report on Egypt OTC Market I Confidential
Sample
Company Name: Pfizer
Year of Establishment: 1849
Headquarter: New York, United Kingdom
Revenue: $81.28 Bn
Website: https://www.pfizer.com
Company Profile
Pfizer
48. 48 A Sample Report on Egypt OTC Market I Confidential
Pfizer (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030
XX
XX
Sample
1 2 3 4
49. A Sample Report on Egypt OTC Market
Healthcare Policy and Regulatory Landscape
50. 50 A Sample Report on Egypt OTC Market I Confidential
Regulatory Framework of Egyptian Drug Market
51. 51 A Sample Report on Egypt OTC Market I Confidential
The Central Administration for Pharmaceutical Affairs (CAPA) is in charge of the registration and pricing of
medicines, as well as the inspection of pharmacies and manufacturing facilities
The CAPA has four registration departments: Licensing and Pharmacist Services, Inspection and Control, and
Importation and Exportation
The CAPA has a department (the Egyptian Pharmacovigilance Center "EPVC") that monitors the use of drugs
and medical devices after they have been registered
The National Organization for Drug Control and Research (NODCR) is in charge of quality control for
pharmaceuticals, medicines, medical plants, cosmetics, raw materials, insecticides, and natural products. Many
laboratories are involved in the organization's testing of all pharmaceutical products under registration that will
be marketed in Egypt.
The National Organization for Research and Control of Biologicals (NORCB) is in charge of marketing
authorizations and licensing
Regulatory Framework of Egyptian Drug Market
Sample
53. 53 A Sample Report on Egypt OTC Market I Confidential
Future Opportunities
Rising GDP per capita, a growing population, and increased health awareness all contribute to an appealing market for
pharmaceutical companies. The government intends to increase healthcare spending to the ambitious target of 3%
Understanding the epidemiologic aspects of any public health problem in terms of its dynamic (prevalence),
distribution, and determinants is critical for prevention and control
Sample
Furthermore, efforts to implement basic universal health insurance should assist the 20% of the population
that does not have public or private health insurance in participating in the prescription drug market
Egypt's public health insurance system currently covers less than half of the population, with out-of-pocket
patient expenditures accounting for the majority of the country's healthcare spending
Sample
54. 54 A Sample Report on Egypt OTC Market I Confidential
Egypt OTC Drug Market is growing and
presents lucrative market opportunity
1
2
3
5
4
Safe and Effective
OTC drugs are safe
and effective when
consumed according to
the physician’s
directions. OTC drugs
can be readily available
in pharmacies and
online health websites
worldwide
Urbanization
Increasing urbanization
will also help
drive the OTC sector in
Egypt, as more of the
population is affected by
issues such as pollution
Insurance
Low-income households and those
without health insurance tend to favour
OTC medicines
Policies
The Central Administration for
Pharmaceutical Affairs (CAPA) is in
charge of the registration and pricing
of medicines, as well as the inspection
of pharmacies and manufacturing
facilities
Future Opportunities
Understanding the
epidemiologic aspects
of any public health
problem in terms of its
dynamic (prevalence),
distribution, and
determinants is critical
for prevention and
control